CS-722 Free base is primarily used in research and development within the pharmaceutical industry. It serves as a key intermediate or active pharmaceutical ingredient (API) in the synthesis of novel therapeutic compounds. Its application is particularly significant in the study of central nervous system (CNS) disorders, where it may be explored for its potential pharmacological effects. Researchers utilize it to investigate its interactions with specific biological targets, aiming to develop treatments for conditions such as anxiety, depression, or neurodegenerative diseases. Additionally, it may be employed in preclinical studies to assess its safety, efficacy, and pharmacokinetic properties, contributing to the advancement of new drug candidates.